Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/1999
07/28/1999EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses
07/28/1999EP0766665B1 Metalloproteinase inhibitors
07/28/1999CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration
07/28/1999CN1223885A Digestive appetitive assimilation-promoting Chinese medicine preparation
07/28/1999CN1223881A Zinc-contg. haw oral liquid and its preparing process
07/28/1999CN1223879A Stomach-benefiting powder
07/27/1999US5929247 Heterocyclic compounds and their preparation and use
07/27/1999US5929213 Antibodies to growth differentiation factor-12
07/27/1999US5929109 Enhancing and stabilizing agent of the activity of Bifidus factor
07/27/1999US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound
07/27/1999US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
07/27/1999US5929032 Method for treating Schwann and colon cells in vitro
07/27/1999US5928640 Administering a protease to human or animal patient to inhibit increased intenstinal fluid seceretion induced by non-bacterial secretagogue
07/27/1999CA2155837C Benzopyrans as potassium channel openers
07/26/1999CA2220854A1 Anti-ulcer composition
07/22/1999WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
07/22/1999WO1999036420A1 Thiophene nitrone compounds
07/22/1999WO1999036415A1 Thioether furan nitrone compounds
07/22/1999WO1999036410A1 Triazine antiviral compounds
07/22/1999WO1999036407A1 Novel allylthiopyridazine derivatives and process for preparing the same
07/22/1999WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION
07/22/1999WO1999036075A1 Oral oil sorbing composition
07/22/1999WO1999036069A1 Il-8 receptor antagonists
07/22/1999WO1999036052A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
07/22/1999WO1999021830A8 Process for stereoselective synthesis of prostacyclin derivatives
07/22/1999CA2318555A1 Thiophene nitrone compounds
07/22/1999CA2318362A1 Triazine antiviral compounds
07/22/1999CA2318357A1 Thioether furan nitrone compounds
07/22/1999CA2318236A1 Oral oil sorbing composition
07/22/1999CA2318195A1 Il-8 receptor antagonists
07/22/1999CA2317956A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
07/21/1999EP0930310A1 Isocoumarin derivatives and use thereof in drugs
07/21/1999EP0930297A1 A process for preparing naphthyridones and intermediates
07/21/1999EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/21/1999EP0929576A1 Glp-2 derivatives
07/21/1999EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
07/21/1999EP0929549A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
07/21/1999EP0929525A2 Novel heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them
07/21/1999EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
07/21/1999EP0929515A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
07/21/1999EP0929323A1 Implantable acrylamide copolymer hydrogel for therapeutic uses
07/21/1999EP0929309A1 Pharmaceutical composition containing a mixed extract of phellodendron amurense ruprecht cortex and patrinia scabiosaefolia fisch. for treatment of hepatitis c
07/21/1999EP0765327B1 Pyrazolo and pyrrolopyridines
07/21/1999CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization
07/21/1999CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors
07/21/1999CN1223641A Aryl pyrimidine derivatives
07/21/1999CN1223257A Preparation of 3,4,4-Trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
07/21/1999CN1223144A Weikang traditional Chinese medicine capsule
07/21/1999CN1223136A Quick-acting preparation for litholysis
07/21/1999CN1223133A Medicine for curing hepatitis B
07/21/1999CN1223127A Tongguanshugan ointment and preparation process thereof
07/20/1999US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups
07/20/1999US5925668 Thioctic metabolites and methods of use thereof
07/20/1999US5925667 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
07/20/1999US5925661 Nervous system disorders
07/20/1999US5925654 Antiinflammatory agents and enzyme inhibitors
07/20/1999US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage
07/20/1999US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos.
07/20/1999US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
07/20/1999CA2162919C Rectal compositions
07/20/1999CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria
07/20/1999CA2024419C Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them
07/15/1999WO1999035252A2 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
07/15/1999WO1999035163A1 Phenylalanine derivatives
07/15/1999WO1999035131A1 Aryl fused azapolycyclic compounds
07/15/1999WO1999035124A1 Matrix metalloprotease inhibitors
07/15/1999WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
07/15/1999WO1999035088A1 Basic aluminum magnesium carbonate, method for the preparation thereof and its use as a pharmaceutical composition for treating stomach acidity
07/15/1999WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
07/15/1999WO1999034765A1 Preparation for dental treatment
07/15/1999CA2316864A1 Secreted proteins and polynucleotides encoding them
07/15/1999CA2316272A1 Preparation for dental treatment
07/15/1999CA2282361A1 Basic aluminum magnesium carbonate, method for the preparation thereof and its use as a pharmaceutical composition for treating stomach acidity
07/14/1999EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds
07/14/1999EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
07/14/1999EP0928198A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis
07/14/1999EP0928196A1 Beta-glucan products and extraction processes from cereals
07/14/1999EP0928184A1 Anti-caries oral compositions
07/14/1999EP0665833B1 Dopamine receptor subtype ligands
07/14/1999EP0658161B1 Substituted thiazolidinedione derivatives
07/14/1999CN1222382A Medicine bolus for hepatitis B and its preparation
07/14/1999CN1222378A Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis
07/14/1999CN1222360A Chinese medicine 'Ganyusan' for treatment of hepatosis
07/14/1999CN1044092C Antigen-antibody-recombination DNA composite type vaccin
07/13/1999US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders
07/13/1999US5922875 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
07/13/1999US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor
07/13/1999US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
07/13/1999US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders.
07/13/1999US5922346 A mixtures of reduced glutathione, selenium or a selenium compound for reducing free radical damage induced by tobacco products and environmental pollutants
07/13/1999CA2005980C Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
07/08/1999WO1999033994A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure
07/08/1999WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
07/08/1999WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines
07/08/1999WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis
07/08/1999WO1999033806A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
07/08/1999WO1999033474A1 The use of mannose for combating protein loss enteropathy
07/08/1999WO1999033466A1 Pharmaceutical composition for oral administration
07/08/1999WO1999025686B1 Cyclic amine derivatives and their use as drugs